MSH homeobox 2 (MSX2) is a transcriptional regulator which belongs to the MSX homeobox gene family. The gene encoding the protein is located on chromosome 5.
Synonyms: Anti-Homeobox protein MSX-2 antibody produced in rabbit; Anti-Hox-8 antibody produced in rabbit
MDL Number: MFCD01633881
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: MSH homeobox 2 (MSX2) is involved in skull (craniofacial) development. Enhanced levels of transcripts for MSX2 are present in a variety of carcinoma cell lines of epithelial origin compared to their corresponding normal tissues. However, this enhanced expression is not found in hematopoietic tumor cells, showing that it plays a more important role in tumors of epithelial origin than in those of hematopoietic origin. MSX2 is an important downstream target for the Ras signaling pathway. Also, it activates cyclin D1 expression and inhibits cellular differentiation suggesting that it is associated with tumorigenesis, since cyclin D1 overexpression is found in various carcinomas like breast and pancreatic cancer. Msx2 is a key regulator of programmed cell death in the BMP-mediated pathway, where bone morphogenetic protein 4 (BMP4) functions as an inducer of its expression and function.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC